|[May 12, 2014]
Research and Markets: Global Pulmonary Drug Delivery Systems Market 2013-2019: Metered Dose Inhalers, Dry Powder Inhalers and Nebulizers
DUBLIN --(Business Wire)--
Research and Markets (http://www.researchandmarkets.com/research/78grt8/pulmonary_drug)
has announced the addition of the "Global
Pulmonary Drug Delivery Systems Market 2013-2019: Metered Dose Inhalers,
Dry Powder Inhalers and Nebulizers" report to their offering.
The market size and forecast for each region has been provided for the
period 2011 to 2019 along with the CAGR (%) for the forecast period 2013
to 2019. The study also includes qualitative analysis of the competitive
scenario in these regions. The market overview section of the report
comprises qualitative analysis of the overall market considering the
factors determining the market dynamics such as drivers, restraints and
opportunities, along with Porter's five force analysis and market
This report studies the current scenario as well as the future market
potential for pulmonary drug delivery systems, globally. The market for
pulmonary drug delivery systems has been segmented into three major
product types, namely, metered dose inhalers (MDIs), dry powder inhalers
(DPIs) and nebulizers.
The market for these systems has been extensively analyzed on the basis
of factors such as therapeutic application, geographic presence and
technological developments. On the basis of therapeutic application, the
market has been segmented into asthma, chronic obstructive pulmonary
disease (COPD) and cystic fibrosis. The market size and forecasts in
terms of revenue (USD million) for each of these segments have been
provided for the period 2011 to 2019, considering 2012 as the base year.
The report also provides the compounded annual growth rate (CAGR) for
each segment of the market for the forecast period 2013 to 2019.
The report also provides a section on the competitive landscape of the
market, wherein the market share analysis of leading players in the
global pulmonary drug delivery systems market, in terms of percentage
share in 2012 has been discussed. A list of recommendations has also
been included for new entrants as well as existing market players to
help them establish a strong presence in the market and accentuate
Pulmonary Drug Delivery Systems Market, by Product Type
Metered Dose Inhalers (MDIs)
Dry Powder Inhalers (DPIs)
Pulmonary Drug Delivery Systems Market, by Application
Chronic Obstructive Pulmonary Disease (COPD)
3M (News - Alert) Health Care
Allied Healthcare Products, Inc.
GF Health Products, Inc.
Merck & Co., Inc.
Omron Healthcare, Inc.
PARI Respiratory Equipment, Inc.
Philips (News - Alert) Healthcare
Sunovion Pharmaceuticals Inc.
For more information visit http://www.researchandmarkets.com/research/78grt8/pulmonary_drug
[ Back To TMCnet.com's Homepage ]